MSOS vs MJ vs YOLO: Which Cannabis ETF Should You Buy?

As cannabis legalization continues to expand across the United States and globally, investors are increasingly turning to exchange-traded funds (ETFs) for diversified exposure to this rapidly evolving sector. Three funds have emerged as the primary vehicles for cannabis investment: AdvisorShares Pure US Cannabis ETF (MSOS), ETFMG Alternative Harvest ETF (MJ), and AdvisorShares Pure Cannabis ETF (YOLO). Each offers distinct approaches to cannabis investing, making the choice between them crucial for portfolio allocation.

With federal cannabis reform still pending and state-level legalization accelerating, 2026 presents both significant opportunities and risks for cannabis investors. Understanding the nuances of each ETF's strategy, holdings, and risk profile is essential for making an informed investment decision.

Holdings Composition and Top Positions

### MSOS: Pure US Multi-State Operator Focus

MSOS takes a concentrated approach to US cannabis investing, focusing exclusively on Multi-State Operators (MSOs) that operate in multiple US states. As of Q4 2024, the fund holds approximately 25-30 positions, with heavy weighting toward the largest US cannabis companies.

Top holdings include: - Green Thumb Industries (GTBIF): ~12-15% allocation - Curaleaf Holdings (CURLF): ~10-13% allocation - Trulieve Cannabis (TCNNF): ~8-11% allocation - Cresco Labs (CRLBF): ~7-10% allocation - Verano Holdings (VRNOF): ~6-9% allocation

The fund's concentrated nature means that the top 10 holdings typically represent 65-75% of total assets, creating significant exposure to individual company performance. This concentration reflects the current state of the US cannabis market, where a handful of large MSOs dominate operations across multiple states.

### MJ: Global Cannabis Ecosystem Exposure

MJ takes the broadest approach among the three funds, offering exposure to the global cannabis ecosystem including Canadian Licensed Producers (LPs), US MSOs, and ancillary businesses that service the cannabis industry.

Top holdings typically include: - Canopy Growth Corporation (CGC): ~8-12% allocation - Tilray Brands (TLRY): ~7-11% allocation - Cronos Group (CRON): ~6-10% allocation - Green Thumb Industries (GTBIF): ~5-8% allocation - GrowGeneration (GRWG): ~4-7% allocation

With approximately 50-60 holdings, MJ offers the most diversified exposure but also includes companies that may have limited direct cannabis revenue. The fund's global approach means exposure to Canadian cannabis companies, which face different regulatory and market dynamics than their US counterparts.

### YOLO: Blended US/International Strategy

YOLO attempts to capture the best of both worlds with a blended approach that includes both US MSOs and international cannabis companies. The fund typically holds 35-45 positions, offering more concentration than MJ but broader diversification than MSOS.

Top holdings generally include: - Green Thumb Industries (GTBIF): ~9-12% allocation - Curaleaf Holdings (CURLF): ~8-11% allocation - Tilray Brands (TLRY): ~6-9% allocation - Trulieve Cannabis (TCNNF): ~5-8% allocation - Canopy Growth Corporation (CGC): ~4-7% allocation

YOLO's strategy reflects an attempt to balance the growth potential of US MSOs with the more established, though currently struggling, Canadian cannabis market.

Expense Ratios and Assets Under Management

Cost structure significantly impacts long-term returns, making expense ratios a critical consideration for cannabis ETF investors.

MSOS carries an expense ratio of 0.74%, which is relatively high compared to broad market ETFs but competitive within the actively managed cannabis space. As of late 2024, the fund manages approximately $350-400 million in assets under management (AUM), making it the largest pure-play US cannabis ETF.

MJ offers the lowest expense ratio at 0.75%, despite being passively managed and tracking the Prime Alternative Harvest Index. The fund's AUM has fluctuated significantly with market volatility, currently sitting around $200-250 million. The larger asset base provides better liquidity and lower tracking error.

YOLO has the highest expense ratio at 0.75%, reflecting its actively managed strategy and smaller scale. With approximately $50-100 million in AUM, YOLO faces potential liquidity constraints and higher operating costs per dollar invested.

The expense ratio differential of 0.01% between funds may seem minimal, but over a 10-year investment horizon, this can translate to meaningful differences in net returns, especially in a volatile sector like cannabis.

Performance Analysis

### Year-to-Date and One-Year Performance

Cannabis ETF performance has been highly volatile, influenced by regulatory developments, earnings results, and broader market sentiment toward growth stocks.

2024 Performance Snapshot: - MSOS: -15% to -25% YTD (as of Q4 2024) - MJ: -20% to -30% YTD - YOLO: -18% to -28% YTD

The underperformance across all three funds reflects ongoing challenges in the cannabis sector, including regulatory uncertainty, cash burn at Canadian LPs, and competitive pressures in mature markets like California and Colorado.

### Since Inception Returns

MSOS (launched April 2020) has faced significant volatility since inception, with peak-to-trough drawdowns exceeding 70%. The fund benefited from the initial cannabis euphoria in 2020-2021 but has struggled with sector-wide challenges including federal illegality, banking restrictions, and intense competition.

MJ (launched December 2015) provides the longest performance track record, having navigated the Canadian legalization cycle and subsequent market correction. The fund's inclusion of ancillary businesses has provided some downside protection during cannabis stock selloffs but has also limited upside participation during rallies.

YOLO (launched April 2019) has experienced similar volatility to MSOS but with slightly less dramatic swings due to its international diversification.

Risk Profile and Volatility

### Regulatory Risk

MSOS carries the highest regulatory risk due to its exclusive focus on US cannabis companies operating in a federally illegal market. Changes in federal enforcement policy, state-level regulations, or federal legalization could dramatically impact holdings.

MJ's global exposure provides some regulatory diversification, though Canadian cannabis companies face their own regulatory challenges around product categories, marketing restrictions, and international expansion.

YOLO falls between the two, with meaningful exposure to both regulatory environments.

### Market Concentration Risk

All three funds exhibit high concentration in cannabis-related stocks, making them susceptible to sector-specific risks including: - Supply chain disruptions - Commodity price volatility - Competitive pressures - Capital market access limitations

### Volatility Metrics

Historical volatility for cannabis ETFs significantly exceeds broader market indices: - Cannabis ETFs: 40-60% annualized volatility - S&P 500: 15-20% annualized volatility - NASDAQ: 20-25% annualized volatility

Tax Implications and 280E Exposure

A critical consideration for cannabis investors is Section 280E of the Internal Revenue Code, which prohibits cannabis companies from deducting ordinary business expenses, resulting in effective tax rates often exceeding 70%.

MSOS has the highest exposure to 280E impact, as all holdings are US cannabis companies subject to this tax provision. This creates a significant competitive disadvantage compared to other industries and limits cash flow generation.

MJ has lower 280E exposure due to its inclusion of: - Canadian cannabis companies (not subject to 280E) - Ancillary businesses (may not be subject to 280E) - International operations

YOLO's 280E exposure falls between MSOS and MJ, depending on the specific allocation between US and international holdings.

For tax-aware investors, the 280E implications could result in a 10-15% annual drag on returns for pure-play US cannabis companies compared to their Canadian counterparts.

Best Use Cases and Investor Suitability

### MSOS: For Pure US Cannabis Believers

Ideal for investors who: - Believe US cannabis legalization is inevitable - Want concentrated exposure to market leaders - Can tolerate high volatility - Have conviction in specific US MSO strategies - Prefer active management

Risk tolerance: High Time horizon: 3-7 years Portfolio allocation: 1-3% for most investors

### MJ: For Diversified Cannabis Exposure

Ideal for investors who: - Want broad cannabis industry exposure - Prefer lower concentration risk - Seek international diversification - Want exposure to ancillary businesses - Prefer passive management

Risk tolerance: Medium-High Time horizon: 3-10 years Portfolio allocation: 2-5% for most investors

### YOLO: For Balanced Approach Seekers

Ideal for investors who: - Want exposure to both US and international markets - Prefer active management with diversification - Seek to balance growth potential with risk - Cannot decide between pure US or global exposure

Risk tolerance: Medium-High Time horizon: 3-7 years Portfolio allocation: 1-4% for most investors

Comparison Summary

| Factor | MSOS | MJ | YOLO | |--------|------|----|----- | | Focus | US MSOs Only | Global + Ancillary | US + International | | Holdings | 25-30 | 50-60 | 35-45 | | Top 10 Concentration | 70-75% | 55-65% | 60-70% | | Expense Ratio | 0.74% | 0.75% | 0.75% | | AUM | $350-400M | $200-250M | $50-100M | | 280E Exposure | High | Low-Medium | Medium | | Regulatory Risk | High | Medium | Medium-High | | Volatility | Very High | High | High | | Management Style | Active | Passive | Active |

Investment Recommendation Framework

For 2026, the choice between these cannabis ETFs should align with your investment thesis and risk tolerance:

Choose MSOS if: You have high conviction that US federal legalization will occur within 3-5 years and believe current MSO market leaders will maintain their advantages. This fund offers the most leveraged exposure to positive US regulatory developments.

Choose MJ if: You want cannabis exposure but prefer diversification across markets and business models. The inclusion of ancillary businesses and international exposure provides some downside protection during US regulatory delays.

Choose YOLO if: You want meaningful US exposure but aren't comfortable with MSOS's concentration risk. The blended approach offers participation in US growth while maintaining some international diversification.

For most investors, a combination approach might be optimal: 60-70% allocation to MSOS for direct US exposure, with 30-40% in MJ for diversification benefits.

Key Takeaways

• MSOS offers the purest US cannabis exposure but carries the highest regulatory and concentration risk, making it suitable for investors with strong conviction about US federal legalization

• MJ provides the broadest diversification across the global cannabis ecosystem, including ancillary businesses that may benefit regardless of direct cannabis regulatory outcomes

• YOLO attempts to balance US growth potential with international diversification but lacks a clear competitive advantage over either MSOS or MJ

• All three funds carry significant 280E tax implications for their US holdings, creating structural disadvantages compared to other sectors

• Portfolio allocation should generally remain limited to 1-5% due to the high volatility and regulatory uncertainty inherent in cannabis investments

• The investment decision should align with your specific thesis on US federal legalization timing and belief in current market leader sustainability